AusPAR: Alirocumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Alirocumab (rch) [PDF, 393.84 KB]

AusPAR: Alirocumab (rch) [Word, 428.52 KB]

Attachment: Product Information for Alirocumab (rch) [PDF, 356.97 KB]

Attachment: Product Information for Alirocumab (rch) [Word, 603.98 KB]

Device/Product Name

Praluent

Active ingredients

Alirocumab (rch)

AusPAR Date

9 December 2019

Published

2 January 2020

Submission Number

PM-2018-02973-1-3

Submission Type

Extension of indications

Decision

Approved